OLIPUDASE ALFA-RPCP

OLIPUDASE ALFA-RPCP was reported 137 times

OLIPUDASE ALFA-RPCP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NIEMANN-PICK DISEASE 1 0.0084
1 BILE ACIDS INCREASED 1 0.0056
2 HYDROCHOLECYSTIS 1 0.0054
3 SCARLET FEVER 1 0.0031
4 OVARIAN CANCER STAGE IV 1 0.0024
5 CHOLESTASIS OF PREGNANCY 1 0.0022
6 INFUSION SITE URTICARIA 1 0.0015
7 AXILLARY MASS 1 0.0010
8 OTITIS EXTERNA 1 0.0008
9 AORTIC VALVE REPLACEMENT 1 0.0008
10 VEIN RUPTURE 1 0.0006
11 EXPOSURE TO SARS-COV-2 1 0.0006
12 UTERINE POLYP 1 0.0006
13 OCCULT BLOOD POSITIVE 1 0.0005
14 HYPERAEMIA 1 0.0005
15 MUSCLE CONTRACTURE 1 0.0005
16 NOSOCOMIAL INFECTION 1 0.0005
17 LYMPHADENITIS 1 0.0004
18 NASAL DISORDER 1 0.0004
19 CLUMSINESS 1 0.0004
20 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
21 STRIDOR 1 0.0003
22 INFUSION SITE REACTION 1 0.0003
23 POOR VENOUS ACCESS 3 0.0003
24 RHINOVIRUS INFECTION 1 0.0003
25 HEPATIC LESION 1 0.0002
26 HORDEOLUM 1 0.0002
27 CATHETERISATION CARDIAC 1 0.0002
28 IRON DEFICIENCY 1 0.0002
29 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
30 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
31 RALES 1 0.0002
32 PROTHROMBIN TIME PROLONGED 1 0.0002
33 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
34 SCOLIOSIS 1 0.0002
35 SWELLING OF EYELID 1 0.0002
36 INFUSION SITE SWELLING 1 0.0002
37 SCREAMING 1 0.0002
38 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
39 SINUS CONGESTION 2 0.0001
40 HYPERTRANSAMINASAEMIA 1 0.0001
41 EXTRASYSTOLES 1 0.0001
42 ARTHROPOD BITE 1 0.0001
43 FURUNCLE 1 0.0001
44 MUSCLE TIGHTNESS 2 0.0001
45 INFUSION SITE ERYTHEMA 1 0.0001
46 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
47 CARDIAC OPERATION 1 0.0001
48 LUNG INFILTRATION 1 0.0001
49 UROSEPSIS 1 0.0001
50 LIGAMENT SPRAIN 1 0.0001
51 TOOTH ABSCESS 1 0.0001
52 BODY TEMPERATURE INCREASED 2 0.0001
53 HYPERBILIRUBINAEMIA 1 0.0001
54 EYE DISCHARGE 1 0.0001
55 WEIGHT FLUCTUATION 1 0.0001
56 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
57 FOOT DEFORMITY 1 0.0001
58 TRANSAMINASES INCREASED 2 0.0001
59 SNEEZING 2 0.0001
60 SPINAL PAIN 1 0.0001
61 BURSITIS 1 0.0001
62 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
63 TACHYPNOEA 1 0.0001
64 ACUTE HEPATIC FAILURE 1 0.0001
65 RESPIRATORY DISTRESS 2 0.0001
66 GASTROENTERITIS 1 0.0001
67 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
68 NERVOUS SYSTEM DISORDER 2 0.0001
69 CYANOSIS 1 0.0001
70 SENSORY DISTURBANCE 1 0.0001
71 TOOTHACHE 1 0.0001
72 ANAPHYLACTIC REACTION 3 0.0001
73 POST PROCEDURAL COMPLICATION 1 0.0001
74 EAR PAIN 1 0.0001
75 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
76 SINUSITIS 5 0.0000
77 ILLNESS 5 0.0000
78 PRODUCT PRESCRIBING ISSUE 1 0.0000
79 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
80 ORAL PAIN 1 0.0000
81 WEIGHT INCREASED 10 0.0000
82 INCORRECT DOSE ADMINISTERED 10 0.0000
83 PNEUMONIA ASPIRATION 1 0.0000
84 INFLAMMATION 2 0.0000
85 EAR INFECTION 1 0.0000
86 RESPIRATORY ARREST 1 0.0000
87 OXYGEN SATURATION DECREASED 2 0.0000
88 INTENTIONAL DOSE OMISSION 1 0.0000
89 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
90 NASAL CONGESTION 2 0.0000
91 RESPIRATORY DISORDER 1 0.0000
92 FEELING HOT 2 0.0000
93 CYSTITIS 1 0.0000
94 METABOLIC ACIDOSIS 1 0.0000
95 NIGHT SWEATS 1 0.0000
96 RHINORRHOEA 2 0.0000
97 HEART RATE INCREASED 3 0.0000
98 VIRAL INFECTION 1 0.0000
99 HEPATIC ENZYME INCREASED 2 0.0000
100 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
101 INFLUENZA 3 0.0000
102 DISORIENTATION 1 0.0000
103 ERYTHEMA 5 0.0000
104 POLLAKIURIA 1 0.0000
105 ROAD TRAFFIC ACCIDENT 1 0.0000
106 URTICARIA 4 0.0000
107 BALANCE DISORDER 2 0.0000
108 ANGIOEDEMA 1 0.0000
109 NASOPHARYNGITIS 4 0.0000
110 OCULAR HYPERAEMIA 1 0.0000
111 INTERSTITIAL LUNG DISEASE 1 0.0000
112 FLUSHING 2 0.0000
113 ABDOMINAL DISTENSION 2 0.0000
114 TREATMENT NONCOMPLIANCE 1 0.0000
115 WEIGHT DECREASED 5 0.0000
116 NECK PAIN 1 0.0000
117 MYALGIA 3 0.0000
118 FLATULENCE 1 0.0000
119 COVID-19 3 0.0000
120 BONE PAIN 1 0.0000
121 WHEEZING 1 0.0000
122 THERAPEUTIC RESPONSE DECREASED 1 0.0000
123 ILL-DEFINED DISORDER 1 0.0000
124 CONDITION AGGRAVATED 5 0.0000
125 HEADACHE 10 0.0000
126 HYPERHIDROSIS 2 0.0000
127 DEEP VEIN THROMBOSIS 1 0.0000
128 INFUSION RELATED REACTION 1 0.0000
129 PYREXIA 5 0.0000
130 COUGH 4 0.0000
131 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
132 INFECTION 2 0.0000
133 RESPIRATORY FAILURE 1 0.0000
134 PAIN IN EXTREMITY 4 0.0000
135 VOMITING 6 0.0000
136 FATIGUE 9 0.0000
137 TACHYCARDIA 1 0.0000
138 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
139 NO ADVERSE EVENT 2 0.0000
140 MIGRAINE 1 0.0000
141 GAIT DISTURBANCE 2 0.0000
142 DRUG INTOLERANCE 1 0.0000
143 HYPOTENSION 2 0.0000
144 RASH 4 0.0000
145 NAUSEA 7 0.0000
146 SEIZURE 1 0.0000
147 CHILLS 1 0.0000
148 DEHYDRATION 1 0.0000
149 NEUTROPENIA 1 0.0000
150 OFF LABEL USE 6 0.0000
151 BLOOD PRESSURE INCREASED 1 0.0000
152 HOSPITALISATION 1 0.0000
153 PARAESTHESIA 1 0.0000
154 PNEUMONIA 2 0.0000
155 DIZZINESS 3 0.0000
156 FALL 2 0.0000
157 ABDOMINAL DISCOMFORT 1 0.0000
158 URINARY TRACT INFECTION 1 0.0000
159 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
160 BLOOD GLUCOSE INCREASED 1 0.0000
161 DYSPNOEA 3 0.0000
162 PRURITUS 2 0.0000
163 PAIN 3 0.0000
164 HYPERTENSION 1 0.0000
165 OVERDOSE 1 0.0000
166 MALAISE 2 0.0000
167 ABDOMINAL PAIN 1 0.0000
168 DIARRHOEA 2 0.0000
169 ASTHENIA 1 0.0000
170 ARTHRALGIA 1 0.0000
171 DRUG INEFFECTIVE 1 0.0000